Press Release: SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition

Dow Jones04:05

In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategy

SURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. $(SNES)$, the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control$(TM)$ products today announced financial results for the first quarter ended March 31, 2026 and provided an update on the Company's acceleration of revenue under newly appointed Chief Executive Officer, Michael Edell.

Q1 2026 Financial Highlights

   -- Revenue increased 2% to $493,000 in Q1 2026 compared to $485,000 in Q1 
      2025, despite approximately $157,000 of reduced third-party e-commerce 
      revenue associated with the Company's transition from third-party 
      e-commerce management to in-house management of Amazon sales. Gross 
      profit increased 8% to $338,000 in Q1 2026 compared to $313,000 in Q1 
      2025. 
 
   -- Direct-to-consumer revenue increased 42% to $194,000 in Q1 2026, compared 
      to $137,000 in Q1 2025, driven by strong Amazon execution and continued 
      subscription growth. 
 
   -- Subscription revenue increased 44% to $56,000 in Q1 2026, compared to 
      $39,000 in Q1 2025, reinforcing the recurring nature of the Company's 
      growing direct-to-consumer business model. 
 
   -- Third party e-commerce revenues declined to $17,000 in Q1 2026 compared 
      to $157,000 in Q1 2025 due to the transition to managing Amazon efforts 
      internally. 
 
   -- B2B revenue increased 57% to $298,000 in Q1 2026 compared to $190,000 in 
      Q1 2025, reflecting continued traction across distributor, municipal, and 
      professional channels. 
 
   -- Gross margin expanded to a company record 68.6% in Q1 2026 as direct 
      channel economics improved and pricing discipline strengthened. 
 
   -- Net loss for Q1 2026 was $2.1 million, compared to $1.7 million in Q1 
      2025. Q1 2026 included $443,000 in severance costs and one-time legal 
      expenses. 
 
   -- Adjusted EBITDA loss was $1.6 million in Q1 2026, compared to 
      $1.5 million in Q1 2025. 
 
   -- Cash and equivalents totaled $6.8 million at quarter end, supporting 
      ongoing operational execution and strategic initiatives. 

April 2026 E-Commerce Momentum

   -- April 2026 represented the first full month following completion of the 
      Company's Amazon transition from third-party e-commerce management to 
      direct in-house management. 
 
   -- E-commerce sales for April 2026 increased 163% to a record $146,000 
      compared to $56,000 during April 2025 and increased 47% compared to 
      $99,000 during March 2026, providing early positive evidence for the 
      Company's evolving e-commerce strategy. 
 
   -- Subscription-based revenue increased 198% to a record $36,000 during 
      April 2026 compared to $12,000 during April 2025, while 
      subscription-based customers increased 109%, reinforcing the recurring 
      nature of the Company's growing direct-to-consumer business model. 

Recent Operational and Strategic Highlights

   -- Appointment of New CEO: Michael Edell's appointment as President and 
      Chief Executive Officer in May 2026 reinforces SenesTech's focus on 
      operational accountability, scalable growth, and disciplined execution. 
      During his tenure as Interim Chief Operating Officer, Mr. Edell helped 
      accelerate the Company's direct-to-consumer strategy, including the 
      transition to direct Amazon management, subscription growth initiatives, 
      packaging redesign efforts, and broader go-to-market execution across 
      e-commerce, distributor, municipal, and other B2B channels. 
 
   -- Amazon Direct Management Transition Completed: SenesTech substantially 
      completed its transition from third party e-commerce management of Amazon 
      sales of Evolve products during March 2026. The transition provides the 
      Company with greater visibility into customer behavior, enhanced control 
      over advertising and media buying, improved pricing visibility, stronger 
      customer engagement opportunities, and greater control over overall 
      channel economics. 
 
   -- E-Commerce Website Redesign Underway: SenesTech continues to redesign the 
      e-commerce section of SenesTech.com to improve customer experience, 
      simplify navigation, increase conversion rates, and support subscription 
      growth. The redesign is expected to align closely with updated packaging, 
      digital advertising initiatives, and broader consumer marketing efforts, 
      with launch currently targeted for Q3 2026. 
 
   -- B2B Vertical Expansion Strategy: SenesTech continues to refine its B2B 
      strategy with increased focus on large-scale opportunities across 
      targeted verticals including pest management, agriculture, municipalities, 
      distributors, and other commercial markets capable of generating larger 
      dollar opportunities. The emphasis on direct-to-consumer growth is also 
      expected to support B2B revenues through increased brand awareness and 
      inbound lead generation. 
 
   -- Packaging Refresh Initiative: SenesTech is implementing updated packaging 
      designed to improve online and shelf visibility and strengthen 
      differentiation. 
 
   -- Municipal Deployment Growth: SenesTech continues to see increased 
      municipal deployment activity across major urban markets, including 
      Chicago, Boston, Washington, D.C., and New York City. The previously 
      announced 12-month New York City rat contraception pilot program is 
      expected to conclude this month. 
 
   -- International Activity: SenesTech continues to pursue international 
      expansion opportunities on an opportunistic basis, with a focus on 
      countries that can move efficiently through the regulatory process with 
      minimal incremental cost to the Company. 

Management Commentary

"SenesTech is entering a new phase where we are building a more scalable, data-driven and recurring revenue business model around the growing demand for non-poison rodent management solutions," said Michael Edell, Chief Executive Officer of SenesTech. "The strategic transition to directly managing our Amazon business and revamping our online e-commerce store has significantly improved our visibility into customer behavior, advertising performance, subscriptions, and overall channel economics. We are already seeing strong momentum in our direct-to-consumer business, particularly through accelerating subscription adoption and improved Amazon execution."

Mr. Edell continued, "Our efforts across Amazon, Shopify, packaging redesign, digital media buying, subscriptions, and customer engagement are all connected initiatives intended to reduce friction, improve conversion, increase customer retention, and create a stronger recurring revenue foundation. At the same time, we remain focused on improving operational discipline, maintaining strong gross margins and positioning the Company for scalable long-term growth."

"Our first quarter results reflected the expected temporary disruption associated with transitioning Amazon operations in-house, however the underlying consumer demand trends and April proof points were highly encouraging," said Tom Chesterman, Chief Financial Officer of SenesTech. "Direct-to-consumer revenue increased 42% to a record $194,000 during Q1, gross margin expanded to a Company record 68.6%, and subscription-based sales continued to accelerate breaking past revenue numbers. We believe these trends support the long-term strategic value of directly controlling our e-commerce channels and building a more predictable recurring revenue mix."

Use of Non-GAAP Measure

Adjusted EBITDA and Adjusted Net Loss are non-GAAP measures. However, these measures are not intended to be a substitute for those financial measures reported in accordance with GAAP. These measures have been included because management believes that, when considered together with the GAAP figures, they provide meaningful information related to operating performance and liquidity trends. We use these non-GAAP financial measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. These adjustments may be calculated by us differently than other companies that disclose measures with the same or similar term. See our attached financials for a reconciliation of the non-GAAP measures to the nearest GAAP measure.

Conference Call Details

Date: Tuesday, May 12, 2026.

Time: 5:00 p.m. ET.

Webcast: https://app.webinar.net/m976bqQblKE.

Webcast Replay: Available for 90 days on the Company's website.

About SenesTech

SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.

For more information visit https://senestech.com/.

Safe Harbor Statement

(MORE TO FOLLOW) Dow Jones Newswires

May 12, 2026 16:05 ET (20:05 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment